Compare SUVEN LIFE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES ABBOTT INDIA SUVEN LIFESCIENCES/
ABBOTT INDIA
 
P/E (TTM) x 20.9 56.1 37.3% View Chart
P/BV x 4.2 13.6 31.3% View Chart
Dividend Yield % 0.5 0.5 97.9%  

Financials

 SUVEN LIFESCIENCES   ABBOTT INDIA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
ABBOTT INDIA
Mar-19
SUVEN LIFESCIENCES/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3388,834 3.8%   
Low Rs1695,458 3.1%   
Sales per share (Unadj.) Rs52.11,731.1 3.0%  
Earnings per share (Unadj.) Rs6.8211.9 3.2%  
Cash flow per share (Unadj.) Rs8.6219.9 3.9%  
Dividends per share (Unadj.) Rs1.5065.00 2.3%  
Dividend yield (eoy) %0.60.9 65.0%  
Book value per share (Unadj.) Rs65.3945.2 6.9%  
Shares outstanding (eoy) m127.2821.25 599.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.94.1 117.8%   
Avg P/E ratio x37.133.7 110.1%  
P/CF ratio (eoy) x29.632.5 91.0%  
Price / Book Value ratio x3.97.6 51.4%  
Dividend payout %22.030.7 71.6%   
Avg Mkt Cap Rs m32,272151,848 21.3%   
No. of employees `0001.13.5 31.0%   
Total wages/salary Rs m6614,356 15.2%   
Avg. sales/employee Rs Th6,132.210,555.5 58.1%   
Avg. wages/employee Rs Th611.11,249.9 48.9%   
Avg. net profit/employee Rs Th803.51,292.2 62.2%   
INCOME DATA
Net Sales Rs m6,63536,786 18.0%  
Other income Rs m2421,133 21.4%   
Total revenues Rs m6,87737,919 18.1%   
Gross profit Rs m1,6046,047 26.5%  
Depreciation Rs m221169 130.9%   
Interest Rs m3823 167.6%   
Profit before tax Rs m1,5876,989 22.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7182,485 28.9%   
Profit after tax Rs m8694,503 19.3%  
Gross profit margin %24.216.4 147.1%  
Effective tax rate %45.235.6 127.2%   
Net profit margin %13.112.2 107.0%  
BALANCE SHEET DATA
Current assets Rs m6,23227,610 22.6%   
Current liabilities Rs m1,4908,569 17.4%   
Net working cap to sales %71.551.8 138.1%  
Current ratio x4.23.2 129.8%  
Inventory Days Days8660 143.5%  
Debtors Days Days8327 301.5%  
Net fixed assets Rs m4,0431,057 382.6%   
Share capital Rs m127213 59.9%   
"Free" reserves Rs m8,18319,873 41.2%   
Net worth Rs m8,31020,086 41.4%   
Long term debt Rs m180-   
Total assets Rs m10,38929,409 35.3%  
Interest coverage x43.1311.6 13.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.3 51.1%   
Return on assets %8.715.4 56.7%  
Return on equity %10.522.4 46.7%  
Return on capital %19.534.9 55.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,622369 1,523.7%   
Fx outflow Rs m1,7994,918 36.6%   
Net fx Rs m3,822-4,549 -84.0%   
CASH FLOW
From Operations Rs m3564,991 7.1%  
From Investments Rs m-279-2,570 10.8%  
From Financial Activity Rs m-225-1,428 15.8%  
Net Cashflow Rs m-148993 -14.9%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.1 213.5%  
Shareholders   37,287 18,270 204.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   DR. REDDYS LAB  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare SUVEN LIFESCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 72 Points Lower; Capital Goods and Auto Stocks Witness Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day marginally lower.

Related Views on News

IPCA LABS at All Time High; BSE HEALTHCARE Index Up 1.2% (Market Updates)

Nov 18, 2019 | Updated on Nov 18, 2019

IPCA LABS share price has hit an all time high at Rs 1,172 (up 5.3%). The BSE HEALTHCARE Index is up by 1.2%. Among the top gainers in the BSE HEALTHCARE Index today are IPCA LABS (up 5.3%) and ABBOTT INDIA (up 3.5%). The top losers include AJANTA PHARMA (down 0.1%) and TORRENT PHARMA (down 0.2%).

IPCA LABS at All Time High; BSE HEALTHCARE Index Up 1.5% (Market Updates)

Nov 18, 2019 | Updated on Nov 18, 2019

IPCA LABS share price has hit an all time high at Rs 1,159 (up 4.0%). The BSE HEALTHCARE Index is up by 1.5%. Among the top gainers in the BSE HEALTHCARE Index today are IPCA LABS (up 4.0%) and ABBOTT INDIA (up 3.1%). The top losers include SYNGENE INTERNATIONAL (down 0.1%) and DISHMAN CARBOGEN AMCIS LTD (down 0.1%).

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Up 1.0% (Market Updates)

Nov 18, 2019 | Updated on Nov 18, 2019

ABBOTT INDIA share price has hit an all time high at Rs 13,200 (up 5.4%). The BSE HEALTHCARE Index is up by 1.0%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 5.4%) and SANOFI INDIA (up 3.5%). The top losers include LAURUS LABS LTD and BLISS GVS PHARMA .

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Up 0.7% (Market Updates)

Nov 18, 2019 | Updated on Nov 18, 2019

ABBOTT INDIA share price has hit an all time high at Rs 12,550 (up 0.8%). The BSE HEALTHCARE Index is up by 0.7%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 0.8%) and SANOFI INDIA (up 0.7%). The top losers include BLISS GVS PHARMA and CAPLIN POINT .

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Nov 18, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - VENUS REMEDIES COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS